Home > Insider Trading > Filing (0001209191-18-047872)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631320	Jr. Donald Michael Abney	12544 High Bluff Drive, Suite 200 San Diego CA 92130	Svp - Distribution	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-08-17	17,596	$15.40	26,153	No	4	M	Direct
Common Stock	Disposition	2018-08-17	17,596	$70.40	8,721	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Disposition	2018-08-17	17,596	$0.00	17,596	$15.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,596		2026-02-10	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $70.40272 per share, with a range of $70.01 to $71.01. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The amount of securities beneficially owned following this transaction include an additional 164 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
17,596 shares vested on 2/10/2018; 8,798 shares will vest on 2/10/2019; 8,798 shares will vest on 2/10/2020.